Real-time enrollment status for this t-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06514794 |
| Recruiting Status | Recruiting |
| Condition | T-Cell Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 125 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Wugen, Inc. |
| Last Updated on CT.gov | January 5, 2026 (Jan 5, 2026) |
As of March 2, 2026: Clinical trial NCT06514794 is currently recruiting participants. This clinical trial study for t-cell acute lymphoblastic leukemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Wugen, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06514794 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06514794 was last updated Jan 5, 2026 (January 5, 2026). HelloStudys verifies this status automatically.